Name: Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval (en Inglés)
SKU: 67386072
Price: 53.94 USD
Availability: InStock
Author: Beverly A. Teicher
ISBN: 9781461581536

portada Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval (en Inglés)

Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval (en Inglés)

Formato

Libro Físico

Editorial

Humana

Autor

Beverly A. Teicher

Año

2013

Idioma

Inglés

N° páginas

330

Encuadernación

Tapa Blanda

Dimensiones

25.4x17.8x1.7 cm

ISBN13

9781461581536

Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval (en Inglés)

Beverly A. Teicher (Autor) · Humana · Tapa Blanda

Libro Nuevo Importado

Envío: 16 a 22 días háb.

$ 107.88$ 53.94

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 53.94

Llega entre el 22 Sep y el 02 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Anticancer Drug Development Guide. Preclinical Screening, Clinical Trials, and Approval (en Inglés)"

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.